Laurel Mcgrane
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$1.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 29, 2026 | NIH | SBIR Phase I Heterocyclic Inhibitors of QcrB as Novel Drugs for Infections Caused by Nontuberculous Mycobacteria | $300K | FIMBRION THERAPEUTICS INC |
| Jul 23, 2025 | NIH | SBIR Phase I Heterocyclic Inhibitors of QcrB as Novel Drugs for Infections Caused by Nontuberculous Mycobacteria | $300K | FIMBRION THERAPEUTICS INC |
| Jan 24, 2024 | NIH | SBIR Phase I FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections | $300K | FIMBRION THERAPEUTICS INC |
| Mar 1, 2023 | NIH | SBIR Phase I FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections | $300K | FIMBRION THERAPEUTICS INC |
| Feb 28, 2023 | NIH | SBIR Phase I FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections | $300K | FIMBRION THERAPEUTICS INC |
Peer ranks
Federal funding#1,352
Awards as PI#417
Patents#273
Companies
- FIMBRION THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.